YCMGA
AGN.PRA

York Capital Management Global Advisors’s Allergan plc AGN.PRA Stock Holding History

York Capital Management Global Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,000
Closed -$9.44M – 123
2015
Q3 		$9.44M Hold
10,000
– – 0.13% 72
2015
Q2 		$10.5M Buy
+10,000
New +$10.5M 0.09% 94

Other funds holding AGN.PRA

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

York Capital Management Global Advisors's AGN.PRA Position: Q4 2015 in Review

York Capital Management Global Advisors sold out of Allergan plc (AGN.PRA) in Q4 2015, closing a stake of 10,000 shares — an estimated $9.44M sold.

York Capital Management Global Advisors first reported a position in AGN.PRA in Q2 2015 and held it in 2 quarters. The position peaked at $10.5M in Q2 2015. 102 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2015.

  • York Capital Management Global Advisors reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • York Capital Management Global Advisors sold 10,000 Allergan plc shares in Q4 2015, an estimated $9.44M.
  • York Capital Management Global Advisors first reported a position in Allergan plc in Q2 2015 and held it in 2 quarters.
  • York Capital Management Global Advisors's Allergan plc position peaked at $10.5M in Q2 2015.
  • 102 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on York Capital Management Global Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.